Top Markets
#1 Status Status +19.34%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.51%
#3 Fake World Assets Fake World Assets +14.92%
#4 GoPlus Security GoPlus Security +14.26%
#5 Ontology Gas Ontology Gas +12.78%
#6 DMT-NAT DMT-NAT +8.79%
#7 Provenance Blockchain Provenance Blockchain +7.02%
#8 Nillion Nillion +6.92%
#9 Janction Janction +6.46%
#10 Bedrock Bedrock +5.82%
Coin of the day
Status Status
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Peringkat dalam Saham #33998
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Harga Saham
$0.1502
Terakhir disinkronkan: 2024-11-04
Kapitalisasi Pasar
$6.43M
Perubahan (1 hari)
-5.45%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Renalytix Plc (RNLX)

Kategori

Healthcare
Jumlah saham beredar untuk Renalytix Plc (RNLX)
Jumlah saham beredar per September 2024: 52.85M
Menurut laporan keuangan terbaru dan harga saham Renalytix Plc, jumlah saham beredar saat ini adalah 52.85M. Pada akhir June 2023, perusahaan memiliki 41.11M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Renalytix Plc (RNLX) dari 2018 hingga 2026
Saham beredar pada akhir setiap tahun
Tahun Saham Beredar Mengubah
2026 (TTM) 52.85M -2.29%
2024 54.09M 31.59%
2023 41.11M 20.93%
2022 33.99M -4.07%
2021 35.43M 22.38%
2020 28.95M 36.05%
2019 21.28M 1.82%
2018 20.90M 0.00%
Saham beredar untuk perusahaan serupa atau pesaing
Perusahaan Saham Beredar Perbedaan Negara
GE HealthCare Technologies Inc. GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc.
GEHC.US
 453.00M 757.16%
US
Pro Medicus Limited Pro Medicus Limited
Pro Medicus Limited
PME.AX
 104.48M 97.70%
AU
BrightSpring Health Services, Inc. Common Stock BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. Common Stock
BTSG.US
 205.38M 288.62%
US
Tempus AI, Inc. Tempus AI, Inc.
Tempus AI, Inc.
TEM.US
 179.92M 240.44%
US
Signify Health, Inc. Signify Health, Inc.
Signify Health, Inc.
SGFY.US
 - -
US